US Stem Cell Inc (USRM)

[Staypositive1]

ASSETS 
$283k Jun 2016 
$413k Sep 2016 
$427k Dec 2016 
$1385k Mar 2017 
$1632k Jun 2017 

Revenues 
$678k Jun 2016 
$729k Sep 2016 
$964k Dec 2016 
$1154k Mar 2017 
$1386k Jun 2017 (Gross profit now $985k in Jun 2017 vs 443k last Jun 2016) 

Cash and Cash Equivalents 
$130k Jun 2016 
$246k Sep 2016 
$270k Dec 2016 
$619k Mar 2017 
$930k Jun 2017 

336,461,515 shares issued and outstanding as of June 30, 2017 vs 327,613million last quarter. :) 

Also, New Clinical trial completed and added July 20, 2017